Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-28 @ 10:44 PM
Study NCT ID:
NCT01640951
Status:
COMPLETED
Last Update Posted:
2018-05-25
First Post:
2012-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-09-16
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-12
First Submit QC Date:
None
Study First Post Date:
2012-07-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-23
Results First Submit QC Date:
None
Results First Post Date:
2018-05-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-24
Last Update Post Date:
2018-05-25
Last Update Post Date Type:
ACTUAL